Drug Rehab Centers in San Antonio Offering Medication-Assisted Treatment

Checkmark Icon Medically Reviewed

More Time. More Joy. More You. Start Now.

WE ACCEPT MOST INSURANCES

Last Updated on September 29, 2026

Yes, there are drug rehab centers in San Antonio that offer medication-assisted treatment for opioid addiction. Nova Recovery Center operates an outpatient addiction treatment program in San Antonio that incorporates medications for opioid use disorder (MOUD) as part of a comprehensive evidence-based approach. Medication-assisted treatment—now more commonly called medications for opioid use disorder—combines FDA-approved medications with counseling and behavioral therapies to address the physiological and psychological dimensions of opioid dependence.

If you or someone you love needs more than detox, Nova Recovery Center also provides drug rehab san antonio.

Nova Recovery Center’s drug and alcohol treatment program provides medically supervised, evidence-based care.

What Medication-Assisted Treatment for Opioid Use Disorder Means

Medication-assisted treatment for opioid use disorder is the clinical use of FDA-approved medications to reduce cravings, prevent withdrawal, and block the euphoric effects of opioids while the patient engages in therapy and builds recovery skills. The terminology has shifted in recent years; many clinicians now prefer “medications for opioid use disorder” (MOUD) to emphasize that the medications themselves are treatment, not merely an adjunct.

Three medications carry FDA approval for opioid use disorder: buprenorphine, methadone, and naltrexone. Buprenorphine is a partial opioid agonist that occupies opioid receptors without producing full euphoria, making it effective for managing cravings and withdrawal with a lower risk of misuse. Methadone is a full agonist dispensed through specialized programs. Naltrexone is an antagonist that blocks opioid receptors entirely, preventing any opioid from producing effects; it is available as a daily tablet or a monthly injection (Vivitrol).

The choice of medication depends on the patient’s history, the severity of dependence, co-occurring conditions, prior treatment attempts, and personal preference. A thorough medical evaluation and honest conversation with a prescriber guide this decision.

Why Drug Rehab Centers in San Antonio Integrate MOUD

Opioid use disorder carries high rates of relapse when treated with counseling alone. Decades of research confirm that combining medication with behavioral therapy produces better retention, lower relapse rates, reduced overdose deaths, and improved quality of life compared to either intervention in isolation. The gold standard treatment for opioid use disorder is this integrated model—medication plus psychosocial support.

Withdrawal from opioids is physically uncomfortable and psychologically demoralizing. Many patients who attempt abstinence-only detox leave treatment early or relapse within days. Medications stabilize brain chemistry, allowing patients to focus on therapy, rebuild routines, repair relationships, and address the underlying drivers of their addiction without the constant distraction of cravings and withdrawal.

Drug rehab centers in San Antonio that offer medication-assisted treatment for opioid addiction recognize that sustainable recovery often requires medical intervention. Stigma around medication persists in some circles, but current clinical guidelines from the American Society of Addiction Medicine, the Substance Abuse and Mental Health Services Administration, and the National Institute on Drug Abuse all endorse MOUD as first-line treatment.

How Nova Recovery Center Delivers MAT in San Antonio

Nova Recovery Center’s San Antonio outpatient program provides medications for opioid use disorder within a structured treatment framework. Patients meet with a prescribing clinician who conducts an assessment, discusses medication options, and initiates or continues the appropriate therapy. Buprenorphine and naltrexone are available; methadone requires enrollment in a federally regulated opioid treatment program and is not offered at Nova’s outpatient sites.

Medication alone is never the entire plan. Patients participate in individual counseling, group therapy, and psychoeducation sessions that address coping skills, relapse prevention, co-occurring mental health conditions, trauma, and the social determinants that complicate recovery. The outpatient schedule allows patients to maintain work, school, or family responsibilities while receiving intensive support.

Insurance verification and payment planning are part of the intake process. Most major commercial plans, Medicaid, and Medicare cover outpatient addiction treatment and MOUD prescriptions, though prior authorization may be required. Nova’s admissions team assists with benefit verification and can discuss payment options for those with limited or no coverage.

Do Rehab Facilities Give Medication During Treatment?

Many do. Inpatient and residential programs may initiate buprenorphine or naltrexone during the acute stabilization phase and continue it throughout the stay. Outpatient facilities prescribe and monitor medications on an ongoing basis, often coordinating with external pharmacies for dispensing. The operational model varies—some programs employ staff physicians or nurse practitioners; others contract with external prescribers or partner with medication clinics.

Not every rehab offers medication. Some adhere to abstinence-only philosophies and discourage or prohibit MOUD, viewing it as substituting one drug for another. This perspective conflicts with current evidence and national treatment standards. Patients seeking medication-assisted treatment should confirm during the admissions call that the facility supports and provides it.

What Is the Newest Treatment for Opioid Addiction?

The medications themselves are not new—buprenorphine received FDA approval in 2002, methadone has been used since the 1960s, and naltrexone was approved for alcohol dependence in 1994 and opioid dependence in 2006. Innovation has focused on formulations and delivery methods. Extended-release buprenorphine implants and monthly injectable buprenorphine (Sublocade) eliminate daily dosing and improve adherence. Long-acting naltrexone (Vivitrol) requires monthly injections, reducing the burden of daily pills.

Research is exploring vaccines that block opioid effects and novel receptor modulators, but none have reached the market. The most impactful recent development is policy change: expanded buprenorphine prescribing authority, elimination of the waiver requirement (the X-waiver), and broader insurance coverage have made existing medications more accessible.

What Is a Good Substitute for Opioids in Pain Management?

This question often arises when patients in recovery need pain control. Non-opioid analgesics—acetaminophen, NSAIDs like ibuprofen or ketorolac, topical agents, nerve blocks, physical therapy, and interventional procedures—manage many types of pain effectively. For severe pain, multimodal strategies combine medications with different mechanisms to minimize reliance on any single agent.

For individuals with opioid use disorder who require surgery or trauma care, buprenorphine can remain on board; additional pain control is achieved by increasing the buprenorphine dose, adding non-opioid medications, or using regional anesthesia. Coordination between the addiction treatment team and the surgical or pain team is essential to avoid triggering relapse while managing legitimate pain.

The Most Common Treatment for Opioid Use Disorder

Buprenorphine is now the most widely prescribed medication for opioid use disorder in the United States, surpassing methadone in outpatient settings. Its safety profile, lower risk of diversion, and availability through office-based prescribing make it accessible in primary care, addiction clinics, and emergency departments. Methadone remains important for patients with long histories of high-dose opioid use who have not succeeded on buprenorphine.

Behavioral therapies—cognitive-behavioral therapy, contingency management, motivational interviewing, and peer support—are integral. The most common and effective treatment combines one of these medications with regular counseling, case management, and recovery support services. This integrated model addresses the biological, psychological, and social aspects of addiction simultaneously.

Finding Drug Rehab Centers in San Antonio That Offer Medication-Assisted Treatment for Opioid Addiction

Patients and families searching for care should ask specific questions during intake calls:

  • Which medications does the program offer—buprenorphine, naltrexone, methadone?
  • Is there a prescriber on staff, or do you refer out for medication management?
  • Can I continue medication started elsewhere, or must I switch?
  • How often will I see the prescriber versus the counselor?
  • Does my insurance cover the medication and the counseling separately?
  • What is the program structure—how many hours per week, how long does treatment last?

These questions reveal whether the facility truly integrates medication into its clinical model or treats it as an afterthought. Programs that view MOUD as essential, not optional, typically produce better outcomes.

Why Location and Continuity Matter

Outpatient medication-assisted treatment requires regular appointments for medication management, urine drug screens, counseling, and group sessions. Proximity to the treatment center reduces transportation barriers and missed appointments, which can derail progress. San Antonio residents benefit from accessing care locally rather than traveling long distances or relocating for residential treatment when outpatient intensity is clinically appropriate.

Nova Recovery Center’s San Antonio outpatient program allows patients to remain in their community, maintain employment, and apply new skills in real-world settings while receiving the structure and accountability that intensive outpatient programming provides. For those who require higher acuity, Nova operates inpatient and residential programs in Austin and Wimberley, Texas, and outpatient services in Austin, Houston, and Colorado Springs, as well as an online intensive outpatient program available from anywhere.

What Happens After Medication Initiation

Starting medication is the beginning, not the endpoint. Patients work with their treatment team to adjust dosing, monitor side effects, and evaluate response. Some experience immediate relief from cravings; others need dose titration over several weeks. Therapy sessions focus on identifying triggers, developing coping strategies, addressing trauma, and building a support network.

Duration of medication varies. Some patients taper off after months or a few years; others continue indefinitely. Research shows that longer treatment durations correlate with better long-term outcomes. The decision to taper is made collaboratively, based on stability, life circumstances, and the patient’s readiness, not arbitrary timelines.

Addressing Stigma and Misconceptions

Myths about medication-assisted treatment persist. “You’re just trading one addiction for another” is the most common. Buprenorphine and methadone are prescribed, monitored, and used to restore normal brain function—not to produce euphoria. Patients on stable doses work, parent, and live full lives without impairment. Naltrexone carries no addiction potential whatsoever.

Another misconception is that medication is a shortcut or sign of weakness. The reality is that opioid use disorder rewires brain chemistry. Expecting willpower alone to overcome a neurobiological condition is like expecting willpower to cure diabetes. Medication corrects the underlying dysfunction, allowing other interventions to succeed.

Families sometimes resist medication, fearing it delays “real” recovery. Education helps. When families understand how MOUD works and see their loved one stable, engaged, and hopeful, resistance often softens. Clinicians who take time to explain the science and involve families in treatment planning build trust and compliance.

Insurance, Payment, and Access

Most insurance plans cover outpatient addiction treatment and medications for opioid use disorder, though coverage details vary. Prior authorization, step therapy, and quantity limits are common. Nova Recovery Center’s admissions staff verifies benefits before admission, clarifying what the plan will cover, what out-of-pocket costs to expect, and whether in-network or out-of-network rates apply.

For patients without insurance or with high deductibles, payment plans may be available. The goal is to remove financial barriers without misrepresenting the program as free or donation-based, which it is not. Transparency during the admissions process prevents surprises and allows families to plan.

When to Seek Drug Rehab Centers in San Antonio That Offer Medication-Assisted Treatment for Opioid Addiction

If you or someone you care about is using opioids daily, has tried to quit and relapsed, is experiencing consequences but cannot stop, or is at risk of overdose, medication-assisted treatment is worth considering. Early intervention prevents progression. Waiting until the situation becomes catastrophic increases medical, legal, and social costs.

Overdose deaths involving opioids remain unacceptably high. Medication reduces that risk dramatically. Naltrexone blocks opioid effects entirely. Buprenorphine raises the overdose threshold and reduces illicit opioid use. Combining medication with counseling gives patients the best chance at sustained recovery and survival.

If you’re ready to explore treatment options or have questions about how medication fits into a recovery plan, Nova Recovery Center’s San Antonio outpatient team is available to discuss your situation and help you take the next step.

Ready to take the next step?

Nova Recovery Center provides inpatient and outpatient drug & alcohol rehab. Call (512) 893-6955 to speak with our team today.

Frequently Asked Questions

Do rehab facilities give medication?
Yes, many rehab facilities provide medications for opioid use disorder, including buprenorphine and naltrexone, as part of a comprehensive treatment plan. Some inpatient programs initiate medication during stabilization, while outpatient centers prescribe and monitor medications on an ongoing basis. Not all facilities offer medication; patients should confirm availability during intake.
What is the newest treatment for opioid addiction?
The medications themselves—buprenorphine, methadone, and naltrexone—have been available for years. Recent innovations include extended-release formulations like monthly injectable buprenorphine (Sublocade) and naltrexone (Vivitrol), which improve adherence by eliminating daily dosing. Policy changes expanding prescribing access have made these medications more widely available.
What is the new term for medication assisted treatment?
The preferred term is now "medications for opioid use disorder" or MOUD. This shift emphasizes that the medications are treatment in themselves, not merely assistive tools. Both terms refer to the same evidence-based approach combining FDA-approved medications with counseling and behavioral therapies.
What is the gold standard treatment for opioid use disorder?
The gold standard is the combination of FDA-approved medications—buprenorphine, methadone, or naltrexone—with psychosocial support such as counseling, behavioral therapy, and case management. Research consistently shows this integrated approach produces better retention, lower relapse rates, and reduced overdose deaths compared to medication or counseling alone.
What is medication assisted treatment for opioid use disorder?
Medication-assisted treatment for opioid use disorder combines FDA-approved medications with counseling and behavioral therapies to treat opioid addiction. The medications reduce cravings, prevent withdrawal, and normalize brain chemistry, allowing patients to engage in therapy and build recovery skills. It addresses both the physiological and psychological dimensions of dependence.
What is the most common treatment for opioid use disorder?
Buprenorphine combined with counseling is now the most common treatment for opioid use disorder in outpatient settings. Its safety profile, lower diversion risk, and availability through office-based prescribing make it widely accessible. Methadone remains important for patients with severe, long-standing dependence who need higher levels of structure.
How long do patients stay on medication for opioid use disorder?
Duration varies by individual. Some patients taper off after several months to a few years, while others continue indefinitely. Research shows longer treatment correlates with better outcomes. The decision to taper is made collaboratively between patient and provider based on stability, life circumstances, and readiness, not arbitrary timelines.
Can I receive medication-assisted treatment while working or going to school?
Yes. Outpatient medication-assisted treatment is designed to allow patients to maintain work, school, and family responsibilities while receiving care. Appointments are scheduled around your commitments, and stable medication doses do not cause impairment. Many patients continue normal daily activities throughout treatment without interruption.

VERIFY YOUR INSURANCE TODAY! (FREE & CONFIDENTIAL)

=
Dr. Robert Ulrich

Dr. Robert Ulrich

Medical Director | Nova Recovery Center

Dr. Robert Ulrich serves as Medical Director at Nova Recovery Center, bringing more than two decades of clinical neurology experience to the treatment of substance use disorders. He is board-certified in neurology by the American Board of Psychiatry and Neurology and completed his neurology residency at UT Southwestern Medical Center in Dallas, where he served as Chief Resident.

Throughout his career in neurology, Dr. Ulrich observed that many patients with neurological conditions also faced challenges related to substance use. In late 2022, he shifted his clinical focus toward addiction medicine, applying his extensive knowledge of brain function, neurochemistry, and the central nervous system to support individuals in recovery.

As Medical Director, Dr. Ulrich provides clinical leadership and helps guide the medical services delivered at Nova Recovery Center. His background in neurology allows him to approach addiction treatment with a detailed understanding of the neurological, physical, and behavioral factors that influence substance use and recovery.

Dr. Ulrich works closely with the clinical team to support individualized, evidence-based treatment plans designed to promote patient safety, stability, and long-term recovery.

Anna-Grace Washington

Medical Content Strategist

Anna-Grace Washington is a Medical Content Writer for Nova Recovery Center. She holds a master’s degree in clinical psychology from the University of Texas and brings a strong understanding of behavioral health, addiction recovery, and evidence-based treatment concepts to her writing. Through her work, Anna-Grace helps create clear, accurate, and compassionate content for individuals and families seeking information about substance use disorders, mental health, and long-term recovery. Her writing reflects Nova Recovery Center’s commitment to education, support, and clinically informed care.
Call Now Button